A systematic review of p53 as a biomarker of survival in patients with osteosarcoma.

Fu, Hai-Liang; Shao, Lin; Wang, Qiang; Jia, Tao; Li, Ming; Yang, Da-Ping

Fu, Hai-Liang; Shao, Lin; Wang, Qiang; Jia, Tao; Li, Ming; Yang, Da-Ping.

Affiliation

Fu HL; Department of Orthopaedic Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, China, drmaster1970@yeah.net.

Tumour Biol ; 34(6): 3817-21, 2013 Dec.

Article in En | MEDLINE | ID: mdl-24014053

Subject(s)

Biomarkers, Tumor/metabolism; Bone Neoplasms/metabolism; Osteosarcoma/metabolism; Tumor Suppressor Protein p53/metabolism; Biomarkers, Tumor/genetics; Bone Neoplasms/genetics; Bone Neoplasms/pathology; Disease-Free Survival; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Osteosarcoma/genetics; Osteosarcoma/pathology; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; Tumor Suppressor Protein p53/genetics

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms / Biomarkers, Tumor / Osteosarcoma / Tumor Suppressor Protein p53 Type of study: Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Tumour Biol Journal subject: NEOPLASIAS Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google